Clinically significant anxiety symptoms are common during the postpartum period and frequently complicate the treatment of postpartum depression.  While SSRIs are indicted for the treatment anxiety symptoms, especially when they co-occur with depression, many women may need to use a benzodiazepine for managing more severe symptoms of anxiety or insomnia.Â
This meta-analysis suggests that mind-body therapies are an effective treatment for women victims of violence.
This review and meta-analysis reviews the effectiveness of cognitive behavioral therapy and mindfulness interventions for depression, anxiety, and cognitive functioning in women undergoing menopausal transition. Â
Overall, parents who conceive through ART experience lower levels of anxiety and depression compared to parents who conceive spontaneously.
More study is needed regarding the safety of sedative-hypnotic medications during pregnancy.
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.
Women undergoing infertility treatment, as well as women who conceived after infertility, experienced significant levels of distress as a result of the COVID-10 pandemic.
Depression and anxiety are prevalent among women who have experienced a stillbirth, especially those reporting inadequate paternal support
Fetal brain development is altered by elevated maternal distress and has adverse infant social-emotional and cognitive outcomes.
